Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nuvation Bio Inc.

    NYSE: NUVB · Real-Time Price · USD
    1.85
    0.12 (6.94%)
    At close: Jun 16, 2025, 3:59 PM
    1.85
    0.00%
    Pre-market: Jun 17, 2025, 05:03 AM EDT

    Nuvation Bio Statistics

    Share Statistics

    Nuvation Bio has 339.26M shares outstanding. The number of shares has increased by 36.62% in one year.

    Shares Outstanding

    n/a
    		 339.26M

    Shares Change (YoY)

    n/a
    		 36.62%

    Shares Change (QoQ)

    n/a
    		 0.33%

    Owned by Institutions (%)

    n/a
    		 72.29%

    Shares Floating

    n/a
    		 226.75M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,149

    FTD / Avg. Volume

    n/a
    		 0.1%

    Short Selling Information

    The latest short interest is 42.33M, so 12.5% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 42.33M

    Short % of Shares Out

    n/a
    		 12.5%

    Short % of Float

    n/a
    		 17.49%

    Short Ratio (days to cover)

    n/a
    		 8.51

    Valuation Ratios

    The PE ratio is -1.26 and the forward PE ratio is -2.74. Nuvation Bio's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.26

    Forward PE

    n/a
    		 -2.74

    PS Ratio

    n/a
    		 90.81

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 1.54

    P/FCF Ratio

    n/a
    		 -5.48

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Nuvation Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 9.04

    Quick Ratio

    n/a
    		 9.04

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.07

    Interest Coverage

    n/a
    		 -1737.91

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $28,838.83

    Profits Per Employee

    n/a
    		 $-2,080,362.64

    Employee Count

    n/a
    		 273

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -36.86% in the last 52 weeks. The beta is 1.37, so Nuvation Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.37

    52-Week Price Change

    n/a
    		 -36.86%

    50-Day Moving Average

    n/a
    		 2.13

    200-Day Moving Average

    n/a
    		 2.4

    Relative Strength Index (RSI)

    n/a
    		 38.43

    Average Volume (20 Days)

    n/a
    		 4,259,539

    Income Statement

    In the last 12 months, Nuvation Bio had revenue of 7.87M and earned -567.94M in profits. Earnings per share was -2.11.

    Revenue

    n/a
    		 7.87M

    Gross Profit

    n/a
    		 795K

    Operating Income

    n/a
    		 -592.63M

    Net Income

    n/a
    		 -567.94M

    EBITDA

    n/a
    		 -566.91M

    EBIT

    n/a
    		 -567.6M

    Earnings Per Share (EPS)

    n/a
    		 -2.11
    Full Income Statement

    Balance Sheet

    The company has 35.72M in cash and 8.91M in debt, giving a net cash position of 26.81M.

    Cash & Cash Equivalents

    n/a
    		 35.72M

    Total Debt

    n/a
    		 8.91M

    Net Cash

    n/a
    		 26.81M

    Retained Earnings

    n/a
    		 -910.74M

    Total Assets

    n/a
    		 492.49M

    Working Capital

    n/a
    		 422.8M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -130.41M and capital expenditures -162K, giving a free cash flow of -130.57M.

    Operating Cash Flow

    n/a
    		 -130.41M

    Capital Expenditures

    n/a
    		 -162K

    Free Cash Flow

    n/a
    		 -130.57M

    FCF Per Share

    n/a
    		 -0.49
    Full Cash Flow Statement

    Margins

    Gross margin is 10.1%, with operating and profit margins of -7527.33% and -7213.76%.

    Gross Margin

    n/a
    		 10.1%

    Operating Margin

    n/a
    		 -7527.33%

    Pretax Margin

    n/a
    		 -7213.76%

    Profit Margin

    n/a
    		 -7213.76%

    EBITDA Margin

    n/a
    		 -7200.75%

    EBIT Margin

    n/a
    		 -7527.33%

    FCF Margin

    n/a
    		 -1658.52%

    Dividends & Yields

    NUVB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NUVB is $10, which is 440.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 440.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.37

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist